26Jul 2023
Evaluating the clinical effectiveness and safety of insulin glargine 300 U/mL in individuals with type 2 diabetes uncontrolled on basal insulin: A real‐world evidence study from Saudi Arabia (EVOLUTION)

Evaluating the clinical effectiveness and safety of insulin glargine 300 U/mL in individuals with type 2 diabetes uncontrolled on basal insulin: A real‐world evidence study from Saudi Arabia (EVOLUTION)

The study evaluated the effectiveness and safety of switching to insulin glargine 300 U/mL (Gla‐U300) in patients with uncontrolled type 2 diabetes (T2D) who were on basal insulin. Data from 718 patients were analyzed, and after switching to Gla‐U300, the mean HbA1c decreased significantly by 0.7%. The percentage of patients with HbA1c levels below 7% increased from 6.4% to 10.3%. The mean daily insulin dose also decreased slightly. The switch to Gla‐U300 was well-tolerated, with a lower incidence of hypoglycemia compared to the previous insulin.

  • #endo-diabetology

Like

Save

Share